Here's Why Merck, Eli Lilly, and Novo Nordisk Stocks Rose 11% Last Month

Submitted by admin on February 8, 2024 - 10:01pm

Source:

Motley Fool

News Tags:

Headline:

snippet:

Demand is surging for weight-loss treatments that are being rolled out by major pharmaceutical companies.
Investors are still trying to assess the full market opportunity and competitive landscape.
It's important to recognize that these stocks' valuations have major implications for risk and potential returns.

Search form